{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:04:33Z","timestamp":1792825473132,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Brain Research \u2013 Inter Disciplinary Guided Excellence"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00787-024-02545-0","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T14:02:42Z","timestamp":1723125762000},"page":"903-919","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Psychotropic drug use among children and adolescents in the Nordic countries: a systematic review"],"prefix":"10.1007","volume":"34","author":[{"given":"D. R.","family":"Ollerup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-6647","authenticated-orcid":false,"given":"L.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. L.","family":"Elkrog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"Stoltz-Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Stubmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-2739","authenticated-orcid":false,"given":"R.","family":"Wesselhoeft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"2545_CR1","unstructured":"Institute for Health Metrics and Evaluation (2019) GBD Compare. Institute for Health Metrics and Evaluation. https:\/\/vizhub.healthdata.org\/gbd-compare\/ Accessed 7 Dec 2021"},{"key":"2545_CR2","unstructured":"Institute for Health Metrics and Evaluation (2019) Global Health Data Exchange (GHDx) - GBD Results. Institute for Health Metrics and Evaluation. https:\/\/vizhub.healthdata.org\/gbd-results\/?params=gbd-api-2019-permalink\/380dfa3f26639cb711d908d9a119ded2 Accessed 14 Oct 2022"},{"key":"2545_CR3","unstructured":"National Institute for Health and Care Excellence (2019) Depression in children and young people: indentification and management. https:\/\/www.nice.org.uk\/guidance\/ng134\/chapter\/Recommendations Accessed 23 May 2022"},{"key":"2545_CR4","unstructured":"National Institute for Health and Care Excellence (2013) Social anxiety disorder: recognition, assessment and treatment. https:\/\/www.nice.org.uk\/guidance\/cg159\/chapter\/Recommendations#identification-and-assessment-of-children-and-young-people Accessed 17 Aug 2022"},{"key":"2545_CR5","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.sleep.2017.03.017","volume":"36","author":"M Ree","year":"2017","unstructured":"Ree M, Junge M, Cunnington D (2017) Australasian sleep association position statement regarding the use of psychological\/behavioral treatments in the management of insomnia in adults. Sleep Med 36:S43\u2013S47. https:\/\/doi.org\/10.1016\/j.sleep.2017.03.017","journal-title":"Sleep Med"},{"key":"2545_CR6","unstructured":"National institute for Health and Care Excellence (2018) Attention deficit hyperactivity disorder: diagnosis and management. https:\/\/www.nice.org.uk\/guidance\/ng87\/chapter\/Recommendations#medication Accessed 17 Aug 2022"},{"key":"2545_CR7","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.euroneuro.2017.07.001","volume":"27","author":"\u00d3 H\u00e1lfd\u00e1narson","year":"2017","unstructured":"H\u00e1lfd\u00e1narson \u00d3, Zo\u00ebga H, Aagaard L, Bernardo M, Brandt L, Fust\u00e9 AC, Furu K, Garuolien\u00e9 K, Hoffmann F, Huybrechts KF et al (2017) International trends in antipsychotic use: a study in 16 countries, 2005\u20132014. Eur Neuropsychopharmacol 27:1064\u20131076. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.07.001","journal-title":"Eur Neuropsychopharmacol"},{"key":"2545_CR8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2215-0366(18)30293-1","volume":"5","author":"SR Raman","year":"2018","unstructured":"Raman SR, Man KKC, Bahmanyar S, Berard A, Bilder S, Boukhris T, Bushnell G, Crystal S, Furu K, KaoYang YH et al (2018) Trends in attention-deficit hyperactivity disorder medication use:a retrospective observational study using population-based databases. Lancet Psychiatry 5:824\u2013835. https:\/\/doi.org\/10.1016\/S2215-0366(18)30293-1","journal-title":"Lancet Psychiatry"},{"key":"2545_CR9","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00228-019-02711-3","volume":"75","author":"D Piovani","year":"2019","unstructured":"Piovani D, Clavenna A, Bonati M (2019) Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data. Eur J Clin Pharmacol 75:1333\u20131346. https:\/\/doi.org\/10.1007\/s00228-019-02711-3","journal-title":"Eur J Clin Pharmacol"},{"key":"2545_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00787-014-0631-y","volume":"24","author":"H-C Steinhausen","year":"2014","unstructured":"Steinhausen H-C (2014) Recent international trends in psychotropic medication prescriptions for children and adolescents. Eur Child Adolesc Psychiatry 24:635\u2013640. https:\/\/doi.org\/10.1007\/s00787-014-0631-y","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2545_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.euroneuro.2016.02.001","volume":"26","author":"CJ Bachmann","year":"2016","unstructured":"Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Kalverdijk LJ, Petersen I, Schuiling-Veninga CCM, Wijlaars L, Zito JM, Hoffmann F (2016) Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005\u20132012. Eur Neuropsychopharmacol 26:411\u2013419. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.02.001","journal-title":"Eur Neuropsychopharmacol"},{"key":"2545_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/acps.13329","volume":"144","author":"R Wesselhoeft","year":"2021","unstructured":"Wesselhoeft R, Rasmussen L, Jensen PB, Jennum PJ, Skurtveit S, Hartz I, Reutfors J, Damkier P, Bliddal M, Potteg\u00e5rd A (2021) Use of hypnotic drugs among children, adolescents, and young adults in Scandinavia. Acta Psychiatr Scand 144:100\u2013112. https:\/\/doi.org\/10.1111\/acps.13329","journal-title":"Acta Psychiatr Scand"},{"key":"2545_CR13","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s00213-021-05809-8","volume":"238","author":"A G\u00f3mez-Lumbreras","year":"2021","unstructured":"G\u00f3mez-Lumbreras A, Garcia Sangenis A, Prat Vallverd\u00fa O, Gatell Carb\u00f3 A, Vedia Urgell C, Gisbert Gustemps L, Bruna P\u00e9rez X, Ramos Quiroga A, Morros Pedr\u00f3s R (2021) Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10-year population-based study. Psychopharmacology 238:1805\u20131815. https:\/\/doi.org\/10.1007\/s00213-021-05809-8","journal-title":"Psychopharmacology"},{"key":"2545_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/acps.13116","volume":"141","author":"R Wesselhoeft","year":"2020","unstructured":"Wesselhoeft R, Jensen PB, Talati A, Reutfors J, Furu K, Strandberg-Larsen K, Damkier P, Potteg\u00e5rd A, Bliddal M (2020) Trends in antidepressant use among children and adolescents: a Scandinavian drug utilization study. Acta Psychiatr Scand 141:34\u201342. https:\/\/doi.org\/10.1111\/acps.13116","journal-title":"Acta Psychiatr Scand"},{"key":"2545_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/oxfordhb\/9780198828389.013.46","volume-title":"The Oxford handbook of the welfare state","author":"M Kautto","year":"2021","unstructured":"Kautto M, Kuitto K (2021) The Nordic countries. In: B\u00e9land D, Leibfried S, Morgan KJ, Obinger H, Pierson C (eds) The Oxford handbook of the welfare state, 2nd edn. Oxford University Press, pp 803\u2013825","edition":"2"},{"key":"2545_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/CLEP.S314959","volume":"13","author":"K Laugesen","year":"2021","unstructured":"Laugesen K, Ludvigsson JF, Schmidt M, Gissler M, Valdimarsdottir UA, Lunde A, S\u00f8rensen HT (2021) Nordic health registry-based research: a review of health care systems and key registries. Clin Epidemiol 13:533\u2013554. https:\/\/doi.org\/10.2147\/CLEP.S314959","journal-title":"Clin Epidemiol"},{"key":"2545_CR17","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100\u2013e1000100. https:\/\/doi.org\/10.1371\/journal.pmed.1000100","journal-title":"PLoS Med"},{"key":"2545_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/9780470712184.ch5","volume-title":"Cochrane Handbook for systematic reviews of interventions","author":"D O'Connor","year":"2008","unstructured":"O\u2019Connor D, Green S, Higgins J (2008) Defining the review question and developing criteria for including studies. In: Green S, Higgins J (eds) Cochrane Handbook for systematic reviews of interventions, 1st edn. Wiley, Wiley Online Library, pp 81\u201394","edition":"1"},{"key":"2545_CR19","unstructured":"National Heart Lung and Blood Institute (2013) Study quality assessment tools - quality assessment tool of obervational cohort and cross-sectional studies. National Heart Lung and Blood Institute. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools Accessed 16 Dec 2021"},{"key":"2545_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174. https:\/\/doi.org\/10.2307\/2529310","journal-title":"Biometrics"},{"key":"2545_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Measur 20:37\u201346. https:\/\/doi.org\/10.1177\/001316446002000104","journal-title":"Educ Psychol Measur"},{"key":"2545_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12888-016-0716-x","volume":"16","author":"I Hartz","year":"2016","unstructured":"Hartz I, Skurtveit S, Steffenak AKM, Karlstad \u00d8, Handal M (2016) Psychotropic drug use among 0\u201317 year olds during 2004\u20132014: a nationwide prescription database study. BMC Psychiatry 16:12\u201312. https:\/\/doi.org\/10.1186\/s12888-016-0716-x","journal-title":"BMC Psychiatry"},{"key":"2545_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2147\/CLEP.S31624","volume":"4","author":"AKM Steffenak","year":"2012","unstructured":"Steffenak AKM, Wilde-Larsson B, Nordstr\u00f6m G, Skurtveit S, Hartz I (2012) Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: a nationwide prescription database study. Clin Epidemiol 4:225\u2013231. https:\/\/doi.org\/10.2147\/CLEP.S31624","journal-title":"Clin Epidemiol"},{"key":"2545_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/acps.12633","volume":"134","author":"I Hartz","year":"2016","unstructured":"Hartz I, Skurtveit S, Hjellvik V, Furu K, Nesv\u00e5g R, Handal M (2016) Antidepressant drug use among adolescents during 2004\u20132013: a population-based register linkage study. Acta Psychiatr Scand 134:420\u2013429. https:\/\/doi.org\/10.1111\/acps.12633","journal-title":"Acta Psychiatr Scand"},{"key":"2545_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1089\/cap.2009.0040","volume":"20","author":"V Foulon","year":"2010","unstructured":"Foulon V, Svala A, Koskinen H, Chen TF, Saastamoinen LK, Bell JS (2010) Impact of regulatory safety warnings on the use of antidepressants among children and adolescents in Finland. J Child Adolesc Psychopharmacol 20:145\u2013150. https:\/\/doi.org\/10.1089\/cap.2009.0040","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2545_CR26","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00787-014-0523-1","volume":"23","author":"A Potteg\u00e5rd","year":"2014","unstructured":"Potteg\u00e5rd A, Zo\u00ebga H, Hallas J, Damkier P (2014) Use of SSRIs among Danish children: a nationwide study. Eur Child Adolesc Psychiatry 23:1211\u20131218. https:\/\/doi.org\/10.1007\/s00787-014-0523-1","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2545_CR27","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00228-012-1233-6","volume":"68","author":"LK Saastamoinen","year":"2012","unstructured":"Saastamoinen LK, Wallin M, Lavikainen P, Airaksinen MS, Sourander A, Bell JS (2012) Treatment duration with selective serotonin reuptake inhibitors among children and adolescents in Finland: a nationwide register study. Eur J Clin Pharmacol 68:1109\u20131117. https:\/\/doi.org\/10.1007\/s00228-012-1233-6","journal-title":"Eur J Clin Pharmacol"},{"key":"2545_CR28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/bcpt.12706","volume":"120","author":"ES Nielsen","year":"2017","unstructured":"Nielsen ES, Rasmussen L, Hellfritzsch M, Thomsen PH, N\u00f8rgaard M, Laursen T (2017) Trends in off-label prescribing of sedatives, hypnotics and antidepressants among children and adolescents - a Danish, nationwide register-based study. Basic Clin Pharmacol Toxicol 120:360\u2013367. https:\/\/doi.org\/10.1111\/bcpt.12706","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2545_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/bcpt.12724","volume":"120","author":"K Furu","year":"2017","unstructured":"Furu K, Karlstad \u00d8, Zoega H, Martikainen JE, Bahmanyar S, Kieler H, Potteg\u00e5rd A (2017) Utilization of stimulants and atomoxetine for attention-deficit\/hyperactivity disorder among 5.4 million children using population-based longitudinal data. Basic Clin Pharmacol Toxicol 120:373\u2013379. https:\/\/doi.org\/10.1111\/bcpt.12724","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2545_CR30","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.euroneuro.2017.03.002","volume":"27","author":"CJ Bachmann","year":"2017","unstructured":"Bachmann CJ, Wijlaars LP, Kalverdijk LJ, Burcu M, Glaeske G, Schuiling-Veninga CCM, Hoffmann F, Aagaard L, Zito JM (2017) Trends in ADHD medication use in children and adolescents in five western countries, 2005\u20132012. Eur Neuropsychopharmacol 27:484\u2013493. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.03.002","journal-title":"Eur Neuropsychopharmacol"},{"key":"2545_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/1403494820901426","volume":"48","author":"M Vuori","year":"2020","unstructured":"Vuori M, Koski-Piril\u00e4 A, Martikainen JE, Saastamoinen L (2020) Gender- and age-stratified analyses of ADHD medication use in children and adolescents in Finland using population-based longitudinal data, 2008\u20132018. Scand J Public Health 48:303\u2013307. https:\/\/doi.org\/10.1177\/1403494820901426","journal-title":"Scand J Public Health"},{"key":"2545_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fpsyt.2020.00316","volume":"11","author":"E Varimo","year":"2020","unstructured":"Varimo E, Saastamoinen LK, R\u00e4tt\u00f6 H, Mogk H, Aronen ET (2020) New users of antipsychotics among children and adolescents in 2008\u20132017: a nationwide register study. Front Psych 11:316\u2013316. https:\/\/doi.org\/10.3389\/fpsyt.2020.00316","journal-title":"Front Psych"},{"key":"2545_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13034-017-0192-1","volume":"11","author":"LJ Kalverdijk","year":"2017","unstructured":"Kalverdijk LJ, Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Hoffmann F, Petersen I, Schuiling-Veninga CCM, Wijlaars LP, Zito JM (2017) A multi-national comparison of antipsychotic drug use in children and adolescents, 2005\u20132012. Child Adolesc Psychiatry Ment Health 11:55\u201355. https:\/\/doi.org\/10.1186\/s13034-017-0192-1","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"2545_CR34","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.euroneuro.2016.07.001","volume":"26","author":"R Nesv\u00e5g","year":"2016","unstructured":"Nesv\u00e5g R, Hartz I, Bramness JG, Hjellvik V, Handal M, Skurtveit S (2016) Mental disorder diagnoses among children and adolescents who use antipsychotic drugs. Eur Neuropsychopharmacol 26:1412\u20131418. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.07.001","journal-title":"Eur Neuropsychopharmacol"},{"key":"2545_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1089\/cap.2020.0095","volume":"31","author":"E Varimo","year":"2021","unstructured":"Varimo E, Aronen ET, Mogk H, R\u00e4tt\u00f6 H, Saastamoinen LK (2021) Antipsychotic treatment duration in children and adolescents: a register-based nationwide study. J Child Adolesc Psychopharmacol 31:421\u2013429. https:\/\/doi.org\/10.1089\/cap.2020.0095","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2545_CR36","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1177\/1403494812464446","volume":"40","author":"I Hartz","year":"2012","unstructured":"Hartz I, Furu K, Bratlid T, Handal M, Skurtveit S (2012) Hypnotic drug use among 0\u201317 year olds during 2004\u20132011: a nationwide prescription database study. Scand J Public Health 40:704\u2013711. https:\/\/doi.org\/10.1177\/1403494812464446","journal-title":"Scand J Public Health"},{"key":"2545_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/bcpt.12411","volume":"117","author":"I Hartz","year":"2015","unstructured":"Hartz I, Handal M, Tverdal A, Skurtveit S (2015) Paediatric off-label use of melatonin \u2013 a register linkage study between the Norwegian prescription database and patient register. Basic Clin Pharmacol Toxicol 117:267\u2013273. https:\/\/doi.org\/10.1111\/bcpt.12411","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2545_CR38","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00787-020-01598-1","volume":"30","author":"EE Kimland","year":"2020","unstructured":"Kimland EE, Bardage C, Collin J, J\u00e4rleborg A, Ljung R, Iliadou AN (2020) Pediatric use of prescribed melatonin in Sweden 2006\u20132017: a register based study. Eur Child Adolesc Psychiatry 30:1339\u20131350. https:\/\/doi.org\/10.1007\/s00787-020-01598-1","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2545_CR39","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00228-015-1866-3","volume":"71","author":"C Furster","year":"2015","unstructured":"Furster C, Hallerb\u00e4ck MU (2015) The use of melatonin in Swedish children and adolescents\u2014a register-based study according to age, gender, and medication of ADHD. Eur J Clin Pharmacol 71:877\u2013881. https:\/\/doi.org\/10.1007\/s00228-015-1866-3","journal-title":"Eur J Clin Pharmacol"},{"key":"2545_CR40","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/archdischild-2013-303646","volume":"98","author":"I Hold\u00f8","year":"2013","unstructured":"Hold\u00f8 I, Handal M, Skurtveit S, Bramness JG (2013) Association between prescribing hypnotics for parents and children in Norway. Arch Dis Child 98:732\u2013736. https:\/\/doi.org\/10.1136\/archdischild-2013-303646","journal-title":"Arch Dis Child"},{"key":"2545_CR41","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/apa.13075","volume":"104","author":"S Bremberg","year":"2015","unstructured":"Bremberg S (2015) Mental health problems are rising more in Swedish adolescents than in other Nordic countries and the Netherlands. Acta P\u00e6diatrica 104:997\u20131004. https:\/\/doi.org\/10.1111\/apa.13075","journal-title":"Acta P\u00e6diatrica"},{"key":"2545_CR42","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/eurpub\/ckx111","volume":"27","author":"IE Thorisdottir","year":"2017","unstructured":"Thorisdottir IE, Asgeirsdottir BB, Sigurvinsdottir R, Allegrante JP, Sigfusdottir ID (2017) The increase in symptoms of anxiety and depressed mood among Icelandic adolescents: time trend between 2006 and 2016. Eur J Pub Health 27:856\u2013861. https:\/\/doi.org\/10.1093\/eurpub\/ckx111","journal-title":"Eur J Pub Health"},{"key":"2545_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1017\/S1121189X00002669","volume":"17","author":"G Schomerus","year":"2008","unstructured":"Schomerus G, Angermeyer MC (2008) Stigma and its impact on help-seeking for mental disorders: what do we know? Epidemiol Psychiatric Sci 17:31\u201337. https:\/\/doi.org\/10.1017\/S1121189X00002669","journal-title":"Epidemiol Psychiatric Sci"},{"key":"2545_CR44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jad.2022.07.002","volume":"313","author":"L Cybulski","year":"2022","unstructured":"Cybulski L, Ashcroft DM, Carr MJ, Garg S, Chew-Graham CA, Kapur N, Webb RT (2022) Management of anxiety disorders among children and adolescents in UK primary care: a cohort study. J Affect Disord 313:270\u2013277. https:\/\/doi.org\/10.1016\/j.jad.2022.07.002","journal-title":"J Affect Disord"},{"key":"2545_CR45","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3238\/arztebl.2016.0396","volume":"113","author":"S Abbas","year":"2016","unstructured":"Abbas S, Ihle P, Adler JB, Engel S, G\u00fcnster C, Linder R, Lehmkuhl G, Sch\u00fcbert I (2016) Psychopharmacological prescriptions in children and adolescents in Germany. Deutsches \u00c4rzteblatt Int 113:396\u2013403. https:\/\/doi.org\/10.3238\/arztebl.2016.0396","journal-title":"Deutsches \u00c4rzteblatt Int"},{"key":"2545_CR46","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.sapharm.2017.07.011","volume":"14","author":"M Green Lauridsen","year":"2018","unstructured":"Green Lauridsen M, K\u00e4lvemark Sporrong S (2018) How does media coverage effect the consumption of antidepressants? A study of the media coverage of antidepressants in Danish online newspapers 2010\u20132011. Res Soc Adm Pharm 14:638\u2013644. https:\/\/doi.org\/10.1016\/j.sapharm.2017.07.011","journal-title":"Res Soc Adm Pharm"},{"key":"2545_CR47","unstructured":"Retsinformation (2012) Vejledning om medikamentel behandling af b\u00f8rn og unge med psykiske lidelser. https:\/\/www.retsinformation.dk\/eli\/retsinfo\/2012\/9415 Accessed 22 Dec 2022"},{"key":"2545_CR48","unstructured":"Retsinformation (2013) Vejledning om medikamentel behandling af b\u00f8rn og unge med psykiske lidelser. https:\/\/www.retsinformation.dk\/eli\/retsinfo\/2013\/9194 Accessed 30 Sept 2023"},{"key":"2545_CR49","unstructured":"R\u00e5det for Anvendelse af Dyr Sygehusmedicin (2015) Behandlingsvejledning inklusiv l\u00e6gemiddelrekommandation for medicinsk behandling af psykotiske tilstande hos b\u00f8rn og unge. https:\/\/rads.dk\/media\/2131\/psykotiske-tilstande-boern-behandlingsvejledning.pdf Accessed 25 May 2022"},{"key":"2545_CR50","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1600-0447.2010.01607.x","volume":"123","author":"H Zo\u00ebga","year":"2011","unstructured":"Zo\u00ebga H, Furu K, Halld\u00f3rsson M, Thomsen PH, Sourander A, Martikainen JE (2011) Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand 123:360\u2013367. https:\/\/doi.org\/10.1111\/j.1600-0447.2010.01607.x","journal-title":"Acta Psychiatr Scand"},{"key":"2545_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00787-019-01416-3","volume":"29","author":"E Barrett","year":"2019","unstructured":"Barrett E, Jacobs B, Klasen H, Herguner S, Agnafors S, Banjac V, Bezborodovs N, Cini E, Hamann C, Huscsava MM et al (2019) The child and adolescent psychiatry: study of training in Europe (CAP-STATE). Eur Child Adolesc Psychiatry 29:11\u201327. https:\/\/doi.org\/10.1007\/s00787-019-01416-3","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2545_CR52","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1089\/cap.2009.0003","volume":"19","author":"H Zo\u00ebga","year":"2009","unstructured":"Zo\u00ebga H, Baldursson G, Hrafnkelsson B, Almarsd\u00f3ttir AB, Valdimarsd\u00f3ttir U, Halld\u00f3rsson M (2009) Psychotropic drug use among icelandic children: a nationwide population-based study. J Child Adolesc Psychopharmacol 19:757\u2013764. https:\/\/doi.org\/10.1089\/cap.2009.0003","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2545_CR53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/08039488.2020.1854853","volume":"75","author":"H Taipale","year":"2021","unstructured":"Taipale H, Puranen A, Mittendorfer-Rutz E, Tiihonen J, Tanskanen A, Cervenka S, L\u00e4hteenvuo M (2021) Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences. Nordic J Psychiatry 75:315\u2013322. https:\/\/doi.org\/10.1080\/08039488.2020.1854853","journal-title":"Nordic J Psychiatry"},{"key":"2545_CR54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00431-006-0299-5","volume":"166","author":"M Skounti","year":"2007","unstructured":"Skounti M, Philalithis A, Galanakis E (2007) Variations in prevalence of attention deficit hyperactivity disorder worldwide. Eur J Pediatr 166:117\u2013123. https:\/\/doi.org\/10.1007\/s00431-006-0299-5","journal-title":"Eur J Pediatr"},{"key":"2545_CR55","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","volume":"398","author":"DF Santomauro","year":"2021","unstructured":"Santomauro DF, Mantilla Herrera AM, Shadid J, Zheng P, Ashbaugh C, Pigott DM, Abbafati C, Adolph C, Amlag JO, Aravkin AY et al (2021) Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet (British edition) 398:1700\u20131712. https:\/\/doi.org\/10.1016\/S0140-6736(21)02143-7","journal-title":"Lancet (British edition)"},{"key":"2545_CR56","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1586\/14737175.8.4.643","volume":"8","author":"JJ Rucklidge","year":"2008","unstructured":"Rucklidge JJ (2008) Gender differences in ADHD: implications for psychosocial treatments. Expert Rev Neurother 8:643\u2013655. https:\/\/doi.org\/10.1586\/14737175.8.4.643","journal-title":"Expert Rev Neurother"},{"key":"2545_CR57","unstructured":"Jeppesen P, Obel C, Lund L, Bang Madsen K, Nielsen L, Nordentoft M (2020) Mental sundhed og sygdom hos b\u00f8rn og unge i alderen 10\u201324 \u00e5r \u2013 forekomst, fordeling og forebyggelsesmuligheder. K\u00f8benhavn: Vidensr\u00e5d for Forebyggelse"},{"key":"2545_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13122","volume":"30","author":"A Hvolby","year":"2021","unstructured":"Hvolby A, Christensen J, Gasse C, Dalsgaard S, Dreier JW (2021) Cumulative incidence and relative risk of sleep problems among children and adolescents with newly diagnosed neurodevelopmental disorders: a nationwide register-based study. J Sleep Res 30:e13122-n\/a. https:\/\/doi.org\/10.1111\/jsr.13122","journal-title":"J Sleep Res"},{"key":"2545_CR59","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12887-021-02529-y","volume":"21","author":"C Lewien","year":"2021","unstructured":"Lewien C, Genuneit J, Meigen C, Kiess W, Poulain T (2021) Sleep-related difficulties in healthy children and adolescents. BMC Pediatr 21:82. https:\/\/doi.org\/10.1186\/s12887-021-02529-y","journal-title":"BMC Pediatr"},{"key":"2545_CR60","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.sleep.2013.08.787","volume":"15","author":"SL Calhoun","year":"2014","unstructured":"Calhoun SL, Fernandez-Mendoza J, Vgontzas AN, Liao D, Bixler EO (2014) Prevalence of insomnia symptoms in a general population sample of young children and preadolescents: gender effects. Sleep Med 15:91\u201395. https:\/\/doi.org\/10.1016\/j.sleep.2013.08.787","journal-title":"Sleep Med"},{"key":"2545_CR61","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/schbul\/sby058","volume":"44","author":"FJ Charlson","year":"2018","unstructured":"Charlson FJ, Ferrari AJ, Santomauro DF, Diminic S, Stockings E, Scott JG, McGrath JJ, Whiteford HA (2018) Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016. Schizophr Bull 44:1195\u20131203. https:\/\/doi.org\/10.1093\/schbul\/sby058","journal-title":"Schizophr Bull"},{"key":"2545_CR62","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jamapsychiatry.2014.16","volume":"71","author":"CB Pedersen","year":"2014","unstructured":"Pedersen CB, Mors O, Bertelsen A, Waltoft BL, Agerbo E, McGrath JJ, Mortensen PB, Eaton WW (2014) A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry (Chicago Ill.) 71:573\u2013581. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.16","journal-title":"JAMA Psychiatry (Chicago Ill.)"},{"key":"2545_CR63","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.schres.2020.03.045","volume":"220","author":"DL Vernal","year":"2020","unstructured":"Vernal DL, Boldsen SK, Lauritsen MB, Correll CU, Nielsen RE (2020) Long-term outcome of early-onset compared to adult-onset schizophrenia: a nationwide Danish register study. Schizophr Res 220:123\u2013129. https:\/\/doi.org\/10.1016\/j.schres.2020.03.045","journal-title":"Schizophr Res"},{"key":"2545_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamapsychiatry.2019.3523","volume":"77","author":"S Dalsgaard","year":"2020","unstructured":"Dalsgaard S, Thorsteinsson E, Trabjerg BB, Schullehner J, Plana-Ripoll O, Brikell I, Wimberley T, Thygesen M, Madsen KB, Timmerman A et al (2020) Incidence rates and cumulative incidences of the full spectrum of diagnosed mental disorders in childhood and adolescence. JAMA Psychiat 77:155\u2013164. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.3523","journal-title":"JAMA Psychiat"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-024-02545-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-024-02545-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-024-02545-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T09:21:59Z","timestamp":1741944119000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-024-02545-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2545"],"URL":"https:\/\/doi.org\/10.1007\/s00787-024-02545-0","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors have consented to the content of this publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}